BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20363967)

  • 1. SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation.
    Fortenbery NR; Paraiso KH; Taniguchi M; Brooks C; Ibrahim L; Kerr WG
    J Immunol; 2010 May; 184(9):5065-74. PubMed ID: 20363967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets.
    Wahle JA; Paraiso KH; Costello AL; Goll EL; Sentman CL; Kerr WG
    J Immunol; 2006 Jun; 176(12):7165-9. PubMed ID: 16751359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell.
    Wahle JA; Paraiso KH; Kendig RD; Lawrence HR; Chen L; Wu J; Kerr WG
    J Immunol; 2007 Dec; 179(12):8009-15. PubMed ID: 18056340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
    Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
    J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
    Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
    J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
    Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
    Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
    Lee KM; Bhawan S; Majima T; Wei H; Nishimura MI; Yagita H; Kumar V
    J Immunol; 2003 May; 170(10):4881-5. PubMed ID: 12734329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.
    Wang JW; Howson JM; Ghansah T; Desponts C; Ninos JM; May SL; Nguyen KH; Toyama-Sorimachi N; Kerr WG
    Science; 2002 Mar; 295(5562):2094-7. PubMed ID: 11896280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
    Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
    J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
    Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
    Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
    Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
    J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
    Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
    Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.
    Lee KM; McNerney ME; Stepp SE; Mathew PA; Schatzle JD; Bennett M; Kumar V
    J Exp Med; 2004 May; 199(9):1245-54. PubMed ID: 15123744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.
    Vaidya SV; Stepp SE; McNerney ME; Lee JK; Bennett M; Lee KM; Stewart CL; Kumar V; Mathew PA
    J Immunol; 2005 Jan; 174(2):800-7. PubMed ID: 15634901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2B4 inhibits NK-cell fratricide.
    Taniguchi RT; Guzior D; Kumar V
    Blood; 2007 Sep; 110(6):2020-3. PubMed ID: 17537992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
    Vaidya SV; Mathew PA
    Immunol Lett; 2006 Jun; 105(2):180-4. PubMed ID: 16621032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand.
    Sinha SK; Gao N; Guo Y; Yuan D
    J Immunol; 2010 Nov; 185(9):5205-10. PubMed ID: 20881194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.
    Lee JE; Lim SA; Kim TJ; Kim K; Ng J; Kim YH; Jang IJ; Oh SB; Lee JC; Yee C; Kumar V; Lee KM
    Eur J Immunol; 2014 Jun; 44(6):1802-13. PubMed ID: 24610736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.